Page last updated: 2024-10-29

ketoprofen and Fibrosarcoma

ketoprofen has been researched along with Fibrosarcoma in 2 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" In the present study, imatinib mesylate and dexketoprofen trometamol were selected as model drugs to develop targeted surface-modified liposome and nanocochleate formulations for fibrosarcoma treatment."7.91Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. ( Altıntaş, L; Arsoy, T; Çoban, Ö; Değim, Z; Sözmen, M; Yılmaz, Ş, 2019)
" In the present study, imatinib mesylate and dexketoprofen trometamol were selected as model drugs to develop targeted surface-modified liposome and nanocochleate formulations for fibrosarcoma treatment."3.91Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. ( Altıntaş, L; Arsoy, T; Çoban, Ö; Değim, Z; Sözmen, M; Yılmaz, Ş, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demirbolat, GM1
Altintas, L2
Yilmaz, S2
Degim, IT1
Çoban, Ö1
Değim, Z1
Arsoy, T1
Sözmen, M1

Other Studies

2 other studies available for ketoprofen and Fibrosarcoma

ArticleYear
Development of Orally Applicable, Combinatorial Drug-Loaded Nanoparticles for the Treatment of Fibrosarcoma.
    Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:5

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Caco-

2018
Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma.
    Drug development research, 2019, Volume: 80, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Caco-2 Cells; Cell Proliferation; Cell Surv

2019